牛嶋 公生 うしじま きみお 先生

来歴等

略歴

1983年 久留米大学医学部 卒業
1990年 医学博士取得
1990年 米国テキサス大学ダラス校留学
1992年 久留米大学産婦人科 助手
1999年 久留米大学産婦人科 講師
2004年 久留米大学産婦人科 助教授（現准教授）
2014年 久留米大学産婦人科 教授

論文

1.牛嶋公生：腎被膜下移植法による制癌剤感受性試験に関する研究。日本産科婦人科学会雑誌 41: 707-714, 1989
2.J Ian Mason, Kimio Ushijima, K. Nagai, D. Naville, JR.Head, L.Milewich, WE.Rainey, MM.Ralph：Regulation of expression of the 3-Hydroxysteroid Dehydrogenases of Human Placenta and Fetal Adrenal. J.Steroid Biochem. Molec.Biol 47: 151-159, 1993
3.牛嶋公生、杉山　徹、西田　敬、薬師寺道明、大蔵尚文、大渕盛夫、綱脇　現、蓮尾泰之、横田大介、天ヶ瀬紀昭、萩尾洋介、池田典文、駒井　幹、本村　聡：上皮性卵巣癌に対するSecond-look operation (SLO)の意義と問題点 日本産科婦人科学会雑誌 51(3): 119-126,1999
4.Kimio Ushijima, Syunichiro Ota, Kan Komai, Go Matsuo, Shigenobu Motoshima, Shizue Honda, Renpei Tomonari, Toru Sugiyama, Toshiharu Kamura: Clinical Assessment of Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Unresectable Advanced Ovarian Cancer. International Surgery 87:185-190, 200
5.Xiao Huang, Kimio Ushijima, Kan Komai, Yumi Takemoto, Shigenobu Motoshima, Toshiharu Kamura, and Kimitoshi Kohno : Co-expression of Y-box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer. Gynecologic Oncology 93: 287-291,2004
6.Ushijima K，Yahata H，Yoshikawa H，Konishi I，Yasugi T，Saito T，Nakanishi T，Sasaki H，Saji F，Iwasaka T，Hatae M，Kodama S，Saito T，Terakawa N，Yaegashi N，Hiura M，Sakamoto A ，Tsuda H，Fukunaga M，Kamura T: Fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women : a multicenter phase II study . J Clin Oncol 25：2798-2803,2007
7.Nishio S, Ushijima K, Tsuda N, Takemoto S, Kawano K, Yamaguchi T, Nishida N, Kakuma T, Tsuda H, Kasamatsu T, Sasajima Y, Kage M, Kuwano M, Kamura T :Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Letters 264: 36-43,2008
8.牛嶋　公生: 子宮体癌における高単位プロゲステロンによる妊孕性温存療法―治療効果および安全性、その後の妊娠について 長期観察結果―. 日本産科婦人科学会誌62: 2107-2114,2010
9.Kimio Ushijima,Toshiharu Kamura, Kazuo Tamura, Kazuo Kuzuya, Toru Sugiyama, Kichiro Noda, Kazunori Ochiai: Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and –resistant ovarian cancer: JGOG/WJGOG Intergroup Study. Int J Clin Oncol 18: 126-131,2013
10.Tsuda N，Ushijima K，Kawano K，Takemoto S，Nishio S，Sonoda G，KamuraT: Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device.J Gynecol Oncol 25(3):229 - 235，2014
11.Ushijima K，Kawano K，Tsuda N，Nishio S，Terada A，Kato H，Matsukuma K: Epithelial borderline ovarian tumor: Diagnosis and treatment strategy. Obstetrics & Gynecolgy Science 58(3):183 - 187，2015
12.Onda T，Satoh T，Saito T，Kasamatsu T，Nakanishi T，Nakamura K，Wakabayashi M，Takehara K，Saito M，Ushijima K，Kobayashi H，Kawana K，Yokota H，Takano M，Takeshima N，Watanabe Y，Yaegashi N，Konishi I，Kamura T，Yoshikawa H:Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602. Eur J Cancer 64:22 - 31，2016
13.Kojiro-Sanada S，Yasuda K，Nishio S，Ogasawara S，Akiba J，Ushijima K，Yano H:CXCL14-CXCR4 and CXCL12-CXCR4 axes may play important roles in the unique invasion process of endometrioid carcinoma with MELF-pattern myoinvasion.Int J Gynecol Pathol 36(6):530 - 539，2017
14.Itamochi H，Oishi T，Oumi N，Takeuchi S，Yoshihara K，Mikami M，Yaegasshi N，Terao Y，Takehara K，Ushijima K，Wtari H，Aoki D，Kimura T，Nakamura T，Yokoyama Y，Kigawa J，Sugiyama T: Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma. Brit J Cancer 117: 717 - 724，2017
15.Matsumoto K，Yaegashi N，Iwata T，Yamamoto K，Nagashima M，Saito T，Ushijima K，Takahashi F，Noda K，Yoshikawa H: Early impact of the Japanese immunization program implemented before the HPV vaccination crisis. Int J Cancer 141:1704 - 1706，2017
16.Nishio S，Takekuma M，Takeuchi S，Kawano K，Tsuda N，Tasaki K，Takahashi N，Abe M，Tanaka A，Nagasawa T，Shoji T，Xiong H，Nuthalapati S，Leahy T，Hashiba H，Kiriyama T，Komarnitsky P，Hirashima Y，Ushijima K: Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer. Cancer Sci 108(11): 2213 - 2220，2017
17.Ushijima K: Fertility sparing treatment for early stage endometrial cancer: current situation and new strategy. J Gynecol Oncol 30(6)，e117，2019
18.Nishio S，Ushijima K: Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer. Japanese Journal of Clinical Oncology 50(4): 379 - 386，2020

著書

1.津田尚武，牛嶋公生：II. 婦人科疾患　G.腫瘍と類腫瘍　4.付属器(卵巣・卵管)の腫瘍・類腫瘍　c.悪性卵巣腫瘍　3)胚細胞腫瘍　産科婦人科疾患最新の治療2016-2018 南江堂：310 – 312,2016
2.牛嶋公生：II婦人科疾患 G類腫瘍と類腫瘍 ３子宮の腫瘍・類腫瘍 i子宮内膜増殖症. 産科婦人科疾患最新の治療2019-2021，241 - 242，南江堂，東京，2019
3.角　明子，牛嶋公生: 膣癌（扁平上皮癌、腺癌）.一冊でわかる婦人科腫瘍の画像診断，90 - 92，文光堂，東京，2019